Status:
COMPLETED
House Calls and Peer Mentorship
Lead Sponsor:
Beth Israel Deaconess Medical Center
Collaborating Sponsors:
Medical University of South Carolina
Patient-Centered Outcomes Research Institute
Conditions:
Chronic Kidney Disease
End-Stage Renal Disease
Eligibility:
All Genders
21+ years
Phase:
NA
Brief Summary
Live donor kidney transplantation (LDKT) offers the most optimal survival and quality of life benefit for those with late-stage chronic kidney disease. However, minorities, especially blacks, are much...
Eligibility Criteria
Inclusion
- Black race (including possible Cape Verdean, Haitian, Dominican)
- ≥18 yrs old
- English speaking
- Meets eligibility criteria for kidney transplant evaluation
- Ability to provide informed consent
- Resides within 1.5 hr drive of HC educator
Exclusion
- Temporarily Unavailable (TU) on the waiting list and TU is likely to exceed 6 months based on judgement of kidney transplant team
- Awaiting combined kidney-liver transplantation
- Awaiting simultaneous pancreas-kidney transplantation
- Participation in another study to increase the likelihood of LDKT
- Prior participation in a transplant HC
- Prior or current participation in the NKF PM program
Key Trial Info
Start Date :
April 30 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 18 2022
Estimated Enrollment :
320 Patients enrolled
Trial Details
Trial ID
NCT03354910
Start Date
April 30 2018
End Date
December 18 2022
Last Update
March 18 2024
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Beth Israel Deaconess Medical Center
Boston, Massachusetts, United States, 02215
2
Medical University of South Carolina
Charleston, South Carolina, United States, 29425